Looking skyward: Three stocks for a post-vaccine world

Which companies are worth keeping an eye on?

clock • 3 min read

Stockmarkets around the world rocketed after the announcement that Pfizer and BioNtech may have found an effective and safe vaccine.

This rise was to be expected on the news that has given the world light at the end of the pandemic tunnel. The initial focus of attention has been on pharma stocks and sectors that have been among the hardest hit by the lockdowns. We are focused, however, on a few global leaders at the epicentre of this crisis that we believe are offering compelling value opportunities. IW Long Reads: How much economic damage can a Covid-19 vaccine repair? These are quality companies in sectors that have suffered from a fall in demand but which crucially are not structurally challenged unlike so...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Alternatives

EY: Allocations to alternatives set to rise by almost a quarter in the next two years

EY: Allocations to alternatives set to rise by almost a quarter in the next two years

Global Alternative Funds survey

Sorin Dojan
clock 13 December 2024 • 2 min read
Hamilton Lane joins forces with Allfunds Blockchain to broaden tokenised access to private markets

Hamilton Lane joins forces with Allfunds Blockchain to broaden tokenised access to private markets

In collaboration with Apex Group

Linus Uhlig
clock 11 December 2024 • 2 min read
Refinitiv's Dewi John: There is little to no 'alternative'

Refinitiv's Dewi John: There is little to no 'alternative'

'Investors, clearly, remain unconvinced'

Dewi John
clock 11 December 2024 • 3 min read
Trustpilot